Clinical trials · Boston, MA
Blastic Plasmacytoid Dendritic Cell Neoplasm clinical trials in Boston
We’re tracking 2 recruiting blastic plasmacytoid dendritic cell neoplasm studies with a site in or near Boston — including Phase 1 and Phase 2 studies, each written for real people, not researchers.
Recruiting studies near Boston
- NCT03779854RecruitingPhase 2
Preventing graft-versus-host disease in kids after stem cell transplant
This trial tests whether removing certain immune cells (T cells) from the donor transplant can lower the risk of chronic graft-versus-host disease (long-term immune attack after transplant) in children and young adults with blood cancers. If you qualify, it may help improve transplant outcomes while tracking safety and side effects.
Boston, MassachusettsAges 6 months–26 years - NCT03113643RecruitingPhase 1
SL-401 with standard drugs for hard-to-treat blood cancers
This Phase 1 study tests SL-401, given with azacitidine and sometimes venetoclax, to treat acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or blastic plasmacytoid dendritic cell neoplasm (BPDCN). It aims to find a safe dose and see whether the combination can improve blood cancer control.
Boston, MassachusettsAges 18 years+
Hear when a new Blastic Plasmacytoid Dendritic Cell Neoplasm trial opens near Boston, MA
We’ll email you when one opens near Boston, MA — at most once a week, no account needed, unsubscribe anytime.
Blastic Plasmacytoid Dendritic Cell Neoplasm trials in other cities
Where these studies are running near Boston
Institutions with a site for the recruiting blastic plasmacytoid dendritic cell neoplasm studies listed above.
- Dana-Farber Cancer Institute
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center
What taking part in a blastic plasmacytoid dendritic cell neoplasm study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting blastic plasmacytoid dendritic cell neoplasm studies in Massachusetts.
Common questions
- Are there blastic plasmacytoid dendritic cell neoplasm clinical trials near Boston?
- Yes. We're currently tracking 2 recruiting blastic plasmacytoid dendritic cell neoplasm studies with a site near Boston, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a blastic plasmacytoid dendritic cell neoplasm study near Boston?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Boston to take part?
- Not necessarily. These studies have a site near Boston, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a blastic plasmacytoid dendritic cell neoplasm trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New blastic plasmacytoid dendritic cell neoplasm studies open near Boston regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.